Media Contact
Researchers at NSW Health Pathology have published a study into the 2023 outbreak of Murray Valley encephalitis virus, including the impact of genomic sequencing in determining the spread of the disease and the crucial One Health collaboration to contain this emergent public health threat.
Murray Valley encephalitis (MVE) is a rare but potentially serious infection of the brain caused by the Murray Valley encephalitis virus (MVEV) – a zoonotic flavivirus.It is spread by mosquitoes from infected animals to humans and although most people who are infected do not experience any symptoms, it has the potential to cause permanent neurological disease or even death.
In 2023, there were 26 reported cases of MVE in Australia, including six in New South Wales.
A comprehensive research study into the diagnostic components of the outbreak was published in the prestigious journal, the Lancet Microbe in June 2025 and involved public health laboratories across Australia.
Link to article
The research assessed how well diagnostic platforms performed during the first six months of the outbreak, as well as testing algorithms and the genomic characteristics of the virus to determine the best way forward for future MVEV testing and surveillance.
The study also acknowledged the impact of a changing climate, with the outbreak occurring after two unseasonably wet summers and a La Niña weather pattern which brought heavy rainfall to the eastern states of Australia.
Medical virologist and study author at NSW Health Pathology’s Institute of Clinical Pathology and Medical Research at Westmead Dr Jen Kok said it’s the largest case series of Murray Valley encephalitis virus from a diagnostic viewpoint.
“We assessed flavivirus diagnostics for all patients with suspected Murray Valley encephalitis.
“Twenty-seven patients were diagnostically assessed for MVEV between Jan 1, 2023, and July 31, 2023, and they ranged from 6 weeks old to 83 years.
“We looked at the diagnostics not just from standard serology, which is traditionally how these infections have been diagnosed, but also from PCRs, or nucleic acid detection, which allows you to do genomic sequencing of the virus.”
Using genomic sequencing, the researchers found there were two concurrently circulating genotypes of MVEV in Australia.
One was circulating in the north and the southeastern parts of the country, while the other was only present in northern parts of Australia.
The impact of a One Health approach
Jen Kok said the research highlighted the importance of a multimodal diagnostic approach.
“The 2023 MVEV outbreak brought together public health laboratories across Australia, along with animal health groups, environmental health organisations and entomologists,” he said.
“It was really the Japanese encephalitis virus (JEV) outbreak the year before in 2022 that paved the way for a One Health approach to diagnostics and laboratory coordination for these outbreaks.”
The research also underlined the importance of continued investment in diagnostic surveillance, particularly with changing weather patterns bringing unseasonal rain and increased transmission of zoonotic disease, which are infectious diseases transmitted between animals and humans.
Mosquito borne disease surveillance in NSW is very effective, to learn more visit our website.
“Surveillance needs to be done using multiple methods and organisations,” he said.
“You need all those areas coming together, because no single surveillance method is complete, in the same way that no single diagnostic method is complete for these outbreaks”.
The research concludes that ongoing One Health surveillance and collaboration is crucial for the early detection of epidemics, to enable prompt action to reduce the public health, animal health, and environmental impacts.